Clinical Enterprise INC

Clinical Enterprise INC was paid $127K by Medicaid between Dec 2020 and Apr 2022, across 2 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 84% of everything it billed.

33Billing provider infoCLINICAL ENTERPRISE INC
FRAMINGHAM, MA 01702

33aNPI1912516352assigned 07/30/2020

33bProvider typeClinical Medical Laboratory

28Total paid$127K

24GClaims2,379

24DCodes billed2

24AFirst – last monthDec 2020 – Apr 2022

Compared with peers

Next to other Clinical Medical Laboratory providers in Massachusetts

Rank by total paid#37 of 63

Median peer was paid$473K

This provider vs. median0.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	50	$5K
2021	1,523	$81K
2022	806	$42K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	84%	1,519	1,379	$107K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	16%	860	787	$20K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialURBANEK, MATTHEW (DIRECTOR)

Same official

Other billing entities under URBANEK, MATTHEW

Full network →

Provider	Location	Paid
Boston Heart Diagnostics Corporation	Framingham, MA	$10.37M
Eurofins NTD LLC	Melville, NY	$5.05M
Eurofins Transplant Genomics, LLC	Lenexa, KS	$483K
Transplant Genomics, INC.	Fremont, CA	$332K
Eurofins Viracor LLC	Lenexa, KS	$64K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.